focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksSKIN.L Share News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen upbeat on promising cannabis skincare test results

Mon, 25th Mar 2019 11:39

(Sharecast News) - Integumen announced positive results from further tests in formulations on Monday, all of which contained low-concentrations of hemp-derived cannabinoid (CBD) oils.The AIM-traded firm said the formulations increased production of pro-collagen, and indicated a reduction of inflammation on 'Labskin', leading to a soothing effect on irritated and sore skin.It explained that pro-collagen had been shown to improve the "youthfulness" of skin appearance, and was a precursor of collagen - the protein that adds strength and support to body tissue.The amount of pro-collagen production could be directly measured, as no additional collagen was added to the Labskin model.Inflammation, meanwhile, could be caused by a variety of reasons ranging from bacterial infection to irritation from harsh skin products, Integumen explained.It said Labskin was capable of releasing chemical markers that indicated inflammation damage occurring on the skin test model.The trial data showed that formulations containing hemp-derived CBD oil, in low concentrations, reduced the release of those inflammation markers, indicating a soothing effect on sore skin.Ingegume's updates on 7 January and 20 February noted that Cellulac, which is 9.35% owned by Integumen, had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the 'STOER For Men' range of cosmetics."Scientific evidence to back up anti-ageing or problematic skin treatments is far superior to anecdotal percentages of product testers," said Integumen chief executive officer Gerard Brandon."With no animal testing allowed, consumers still have a right to know what the real impact and effect of products have on their skin, before they use it."Further tests and product approvals were still required before consideration of launching an extension to the range of STOER For Men skin care products, Brandon explained."Labskin is now offering the same test services to clients adding CBD to their skin-care and cosmetic range of products."
More News
30 Sep 2020 17:10

Integumen enters deal with Detroit water quality non-profit

(Sharecast News) - Integumen has signed a memorandum of understanding with Detroit-based non-profit organisation Water Rising Institute, it announced on Wednesday, to enter a legally-binding three-year framework agreement.

Read more
25 Sep 2020 10:32

UK WINNERS & LOSERS SUMMARY: Boohoo Rallies After Supply Chain Review

UK WINNERS & LOSERS SUMMARY: Boohoo Rallies After Supply Chain Review

Read more
25 Sep 2020 10:21

Integumen And Modern Water Get Publication Date Extension For Merger

Integumen And Modern Water Get Publication Date Extension For Merger

Read more
18 Sep 2020 14:23

IN BRIEF: Integumen Revenue Jumps But Loss Only Slightly Narrows

IN BRIEF: Integumen Revenue Jumps But Loss Only Slightly Narrows

Read more
28 Aug 2020 13:20

Integumen agrees deal to take over Modern Water

(Sharecast News) - Integumen and Modern Water have reached agreement on the terms of a recommended offer to be made by Integumen for the entire issued and to be issued share capital of Modern Water, they announced on Friday.

Read more
28 Aug 2020 10:47

Integumen Agrees GBP21 Million All-Share Acquisition Of Modern Water

Integumen Agrees GBP21 Million All-Share Acquisition Of Modern Water

Read more
29 Jul 2020 21:19

IN BRIEF: Integumen Secures GBP3 Million Facility For Working Capital

IN BRIEF: Integumen Secures GBP3 Million Facility For Working Capital

Read more
29 Jul 2020 13:53

Integumen secures £3m loan to fund Covid-19 AI goals

(Sharecast News) - Integumen announced on Wednesday that it has secured a £3m, three-year loan facility with Riverfort Global Opportunities and YA II PN.

Read more
24 Jul 2020 15:37

Integumen's Labskin launches remote clinical trials platform

(Sharecast News) - Integumen announced on Friday that its subsidiary Labskin was launching its remote clinical skin trials platform, which it claimed was the world's first of its type.

Read more
24 Jul 2020 13:56

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

Read more
13 Jul 2020 11:23

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Avacta Partners With Integumen To Detect Covid-19 In Waste Water

Read more
13 Jul 2020 09:18

Avacta signs Covid sewage test deal with Integumen

(Sharecast News) - Biotherapeutics company Avacta Group has entered into a collaboration with its AIM peer Integumen, it announced on Monday, to evaluate recently-generated Affimer reagents that bind the SARS-CoV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localised Covid-19 outbreaks.

Read more
23 Jun 2020 06:47

IN BRIEF: Integumen Signs Covid Identification Pact With Aptamer Group

IN BRIEF: Integumen Signs Covid Identification Pact With Aptamer Group

Read more
22 Jun 2020 16:36

Integumen signs deal for Covid-19 detection in wastewater

(Sharecast News) - Integumen has signed a material transfer agreement with the Aptamer Group, it announced on Monday, to develop and manufacture aptamers to detect SARS-CoV-2, or Covid-19, in wastewater.

Read more
15 Jun 2020 13:54

UPDATE: Integumen Obtains GBP400,000 Loan From Cellulac

UPDATE: Integumen Obtains GBP400,000 Loan From Cellulac

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.